Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prostate Cancer
100%
Therapeutic Agents
100%
In Vitro Evaluation
100%
1,25(OH)2D3
100%
25-hydroxyvitamin D3
100%
NOR-1
100%
25(OH)D3
70%
Vitamin D Receptor
60%
Primary Culture
50%
PC-3
40%
Chloramphenicol Acetyltransferase
30%
Prostate Cells
20%
Hypercalcemia
20%
CYP27B1
20%
Receptor Cells
20%
Deacetylase Activity
20%
Inhibitory Effect
10%
3H-thymidine Incorporation
10%
Antiproliferative Activity
10%
Clinical Trials
10%
Cancer Cell Lines
10%
Incubation
10%
Cell Proliferation
10%
LNCaP Cells
10%
Prostate Cancer Cells
10%
Prostate Radiotherapy
10%
Specific Receptor
10%
Transactivation
10%
Androgen-independent
10%
Fold Increase
10%
Prohormone
10%
Human Prostate Cancer Cells
10%
Invasiveness
10%
Human Prostate
10%
Reporter Gene
10%
Vitamin D
10%
Human Trials
10%
Primary Cells
10%
Hydroxylated
10%
Parathyroid Disease
10%
Cell Line Culture
10%
Transactivation Assay
10%
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3)
10%
Gene Transactivation
10%
Human Use
10%
Vitamin D Compounds
10%
Compound 25
10%
Dose-dependent
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Vitamin D Receptor
100%
Calcifediol
100%
1,25 Dihydroxyergocalciferol
100%
Primary Culture
83%
Chloramphenicol Acetyltransferase
50%
Clinical Trial
33%
Hypercalcaemia
33%
Oxygenase
33%
Vitamin D
33%
Thymidine
16%
Malignant Neoplasm
16%
Androgen
16%
Receptor
16%
Enzymes
16%
Hormone Precursor
16%
Calcitriol
16%
Antiproliferative Activity
16%
Parathyroid Disease
16%
Biochemistry, Genetics and Molecular Biology
Primary Culture
100%
Vitamin D
100%
Calcifediol
100%
Cancer Cell
60%
Chloramphenicol Acetyltransferase
60%
Cholecalciferol
60%
Clinical Trial
40%
Transactivation
40%
Oxygenase
40%
Hypercalcaemia
40%
Enzyme
20%
DNA Synthesis
20%
Cell Proliferation
20%
LNCaP
20%
Reporter Gene
20%
Antiproliferative Activity
20%
Calcitriol
20%